{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:23:19Z","timestamp":1754486599216,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scientific Research Foundation for Talented Scholars in Soochow University","award":["Q413900215"],"award-info":[{"award-number":["Q413900215"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10147-021-02110-8","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T06:08:41Z","timestamp":1642054121000},"page":"765-773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hormone replacement therapy in relation to the risk of colorectal cancer in women by BMI: a multicentre study with propensity score matching"],"prefix":"10.1007","volume":"27","author":[{"given":"Lingkai","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongkui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4933-5851","authenticated-orcid":false,"given":"Xiaochen","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"issue":"2","key":"2110_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87\u2013108","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2110_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115\u2013132","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2110_CR3","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJM200006293422606","volume":"54","author":"PA J\u00e4nne","year":"2000","unstructured":"J\u00e4nne PA, Mayer RJ (2000) Chemoprevention of colorectal cancer. N Engl J Med 54(1):1960\u20131968","journal-title":"N Engl J Med"},{"issue":"2","key":"2110_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1677\/erc.1.00861","volume":"12","author":"V Martineti","year":"2005","unstructured":"Martineti V, Picariello L, Tognarini I et al (2005) ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer 12(2):455\u2013469","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2110_CR5","first-page":"245","volume":"60","author":"EF Foley","year":"2000","unstructured":"Foley EF, Jazaeri AA, Shupnik MA et al (2000) Selective loss of estrogen receptor \u03b2 in malignant human colon. Cancer Res 60(2):245\u2013248","journal-title":"Cancer Res"},{"issue":"4","key":"2110_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ng0894-536","volume":"7","author":"JP Issa","year":"1994","unstructured":"Issa JP, Ottaviano YL, Celano P et al (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7(4):536\u2013540","journal-title":"Nat Genet"},{"issue":"2","key":"2110_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1752-8062.2008.00040.x","volume":"1","author":"P Li","year":"2008","unstructured":"Li P, Lin JE, Snook AE et al (2008) Colorectal cancer is a paracrine deficiency dyndrome amenable to oral hormone replacement therapy. Clin Transl Sci 1(2):163\u2013167","journal-title":"Clin Transl Sci"},{"issue":"8","key":"2110_CR8","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10552-005-4500-3","volume":"16","author":"MP Purdue","year":"2005","unstructured":"Purdue MP, Mink PJ, Hartge P et al (2005) Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Cancer Causes Control 16(8):965\u2013973","journal-title":"Cancer Causes Control"},{"issue":"10","key":"2110_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa032071","volume":"350","author":"RT Chlebowski","year":"2004","unstructured":"Chlebowski RT, Wactawski-Wende J, Ritenbaugh C et al (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350(10):991\u20131004","journal-title":"N Engl J Med"},{"issue":"8","key":"2110_CR10","first-page":"321","volume":"131","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial. JAMA 131(8):321\u2013333","journal-title":"JAMA"},{"issue":"14","key":"2110_CR11","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/jnci\/87.14.1067","volume":"87","author":"PA Newcomb","year":"1995","unstructured":"Newcomb PA, Storer BE (1995) Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87(14):1067\u20131071","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2110_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1023\/A:1018455810238","volume":"8","author":"R Troisi","year":"1997","unstructured":"Troisi R, Schairer C, Chow WH et al (1997) A prospective study of menopausal hormones and risk of colorectal cancer (United States). Cancer Causes Control 8(2):130\u2013138","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2110_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/aje\/kwp434","volume":"171","author":"K Delellis Henderson","year":"2010","unstructured":"Delellis Henderson K, Duan L, Sullivanhalley J et al (2010) Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study. Am J Epidemiol 171(4):415\u2013425","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2110_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ijc.23079","volume":"122","author":"GC Kabat","year":"2008","unstructured":"Kabat GC, Miller AB, Rohan TE (2008) Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women. Int J Cancer 122(3):643\u2013646","journal-title":"Int J Cancer"},{"issue":"23","key":"2110_CR15","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/jnci\/93.23.1799","volume":"93","author":"K Woodson","year":"2001","unstructured":"Woodson K, Lanza E, Tangrea JA et al (2001) Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst 93(23):1799\u20131805","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2110_CR16","first-page":"1075","volume":"22","author":"KK Tsilidis","year":"2011","unstructured":"Tsilidis KK, Allen NE, Key TJ et al (2011) Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 22(8):1075\u20131084","journal-title":"Int J Cancer"},{"issue":"1","key":"2110_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/bjc.2016.345","volume":"116","author":"N Murphy","year":"2016","unstructured":"Murphy N, Xu L, Zervoudakis A et al (2016) Reproductive and menstrual factors and colorectal cancer incidence in the Women\u2019s Health Initiative Observational Study. Br J Cancer 116(1):117\u2013125","journal-title":"Br J Cancer"},{"issue":"4","key":"2110_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/cen.13098","volume":"85","author":"M Nouri","year":"2016","unstructured":"Nouri M, Aghadavod E, Khani S et al (2016) Association between BMI and gene expression of anti-M\u00fcllerian hormone and androgen receptor in human granulosa cells in women with and without polycystic ovary syndrome. Clin Endocrinol 85(4):590\u2013595","journal-title":"Clin Endocrinol"},{"issue":"854","key":"2110_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8591986","volume":"2017","author":"Y Wang","year":"2017","unstructured":"Wang Y, Yin Q, Xu M et al (2017) BMI modulates the effect of thyroid hormone on lipid profile in euthyroid adults. Int J Endocrinol 2017(854):1\u20138","journal-title":"Int J Endocrinol"},{"issue":"12","key":"2110_CR20","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1038\/oby.2007.355","volume":"15","author":"JF Carroll","year":"2007","unstructured":"Carroll JF, Kaiser KA, Franks SF et al (2007) Influence of BMI and gender on postprandial hormone responses. Obesity 15(12):2974\u20132983","journal-title":"Obesity"},{"issue":"1","key":"2110_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/aje\/kwm049","volume":"166","author":"KF Adams","year":"2007","unstructured":"Adams KF, Leitzmann MF, Albanes D et al (2007) Body mass and colorectal cancer risk in the NIH\u2013AARP cohort. Am J Epidemiol 166(1):36\u201345","journal-title":"Am J Epidemiol"},{"issue":"13","key":"2110_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/jnci\/djj246","volume":"98","author":"T Pischon","year":"2007","unstructured":"Pischon T, Lahmann PH, Boeing H et al (2007) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98(13):920\u2013931","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"2110_CR23","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/sj.bjc.6604066","volume":"97","author":"M Hoffmeister","year":"2007","unstructured":"Hoffmeister M, Raum E, Winter J et al (2007) Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany. Br J Cancer 97(11):1486\u20131492","journal-title":"Br J Cancer"},{"issue":"4","key":"2110_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ijc.2910430409","volume":"43","author":"FG Davis","year":"1989","unstructured":"Davis FG, Furner SE, Persky V et al (1989) The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer 43(4):587\u2013590","journal-title":"Int J Cancer"},{"issue":"8","key":"2110_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00384-018-3017-7","volume":"33","author":"Y Feng","year":"2018","unstructured":"Feng Y, Dai W, Li Y et al (2018) The effect of marital status by age on patients with colorectal cancer over the past decades: a SEER-based analysis. Int J Colorectal Dis 33(8):1001\u20131010","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"2110_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.gie.2010.06.022","volume":"72","author":"SN Hong","year":"2010","unstructured":"Hong SN, Kim JH, Choe WH et al (2010) Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointest Endosc 72(3):480\u2013489","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"2110_CR27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/DCR.0b013e3181d320b1","volume":"53","author":"A-C Lo","year":"2010","unstructured":"Lo A-C, Soliman AS, Khaled HM et al (2010) Lifestyle, occupational, and reproductive factors and risk of colorectal cancer. Dis Colon Rectum 53(5):830\u2013837","journal-title":"Dis Colon Rectum"},{"key":"2110_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/jwh.2008.1068","volume":"18","author":"KJ Wernli","year":"2009","unstructured":"Wernli KJ, Wang Y, Zheng Y et al (2009) The relationship between gravidity and parity and colorectal cancer risk. J Womens Health (Larchmt) 18:7","journal-title":"J Womens Health (Larchmt)"},{"issue":"11","key":"2110_CR29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/bjc.1996.272","volume":"73","author":"E Fernandez","year":"1996","unstructured":"Fernandez E, La VC, D\u2019Avanzo B et al (1996) Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 73(11):1431\u20131435","journal-title":"Br J Cancer"},{"issue":"27","key":"2110_CR30","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1200\/JCO.2009.22.0764","volume":"27","author":"G Rennert","year":"2009","unstructured":"Rennert G, Rennert HS, Pinchev M et al (2009) Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol 27(27):4542\u20134547","journal-title":"J Clin Oncol"},{"issue":"3","key":"2110_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3109\/13697137.2012.659450","volume":"15","author":"EL Barnes","year":"2012","unstructured":"Barnes EL, Long MD (2012) Colorectal cancer in women: hormone replacement therapy and chemoprevention. Climacteric 15(3):250\u2013255","journal-title":"Climacteric"},{"issue":"5","key":"2110_CR32","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1055-9965.EPI-08-1209","volume":"18","author":"RL Prentice","year":"2009","unstructured":"Prentice RL, Pettinger M, Beresford SA et al (2009) Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women\u2019s Health Initiative clinical trial and observational Study. Cancer Epidemiol Biomarkers Prev 18(5):1531\u20131537","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"16","key":"2110_CR33","first-page":"3983","volume":"31","author":"MS Simon","year":"2013","unstructured":"Simon MS, Chlebowski RT, Wactawskiwende J et al (2013) Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol 31(16):3983\u20133990","journal-title":"J Clin Oncol"},{"issue":"11","key":"2110_CR34","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1158\/0008-5472.CAN-12-4051","volume":"73","author":"A Rudolph","year":"2013","unstructured":"Rudolph A, Toth C, Hoffmeister M et al (2013) Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-\u03b2. Cancer Res 73(11):3306\u20133315","journal-title":"Cancer Res"},{"issue":"6","key":"2110_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1023\/B:CACO.0000036168.23351.f1","volume":"15","author":"J Lin","year":"2004","unstructured":"Lin J, Zhang SM, Cook NR et al (2004) Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control 15(6):581\u2013589","journal-title":"Cancer Causes Control"},{"issue":"12","key":"2110_CR36","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1158\/1055-9965.EPI-06-0499","volume":"15","author":"M Somdat","year":"2006","unstructured":"Somdat M, David JB, Laura LJ et al (2006) Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15(12):2502\u20132507","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"2110_CR37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10552-004-7472-9","volume":"16","author":"DB Irene","year":"2005","unstructured":"Irene DB, Sabina R, Laure D et al (2005) C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 16(5):561\u2013572","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2110_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ijc.30122","volume":"139","author":"H Akiko","year":"2016","unstructured":"Akiko H, Shuji O, Zhi RQ et al (2016) Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer 139(4):854\u2013868","journal-title":"Int J Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-02110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-021-02110-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-02110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T04:33:13Z","timestamp":1648269193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-021-02110-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2110"],"URL":"https:\/\/doi.org\/10.1007\/s10147-021-02110-8","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interests was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The written informed consent forms for participation and publication were obtained for all study participants. Information on individual record of all patients was de-identified prior to the analysis on order to preserve anonymity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Our research protocols were approved by the institutional review boards of Soochow University and the respective ethical committees at the participating hospitals. The present study was conducted according to the tenets of the Declaration of Helsinki of the World Medical Association regarding scientific research on human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}